Comparative analysis of morphological and biochemical changes after a single intragastric administration of hybrid organotin compounds
https://doi.org/10.29001/2073-8552-2023-38-1-167-174
Abstract
Introduction. Organotin compounds are promising candidates for antitumor drugs. Identification of pathogenetic features of the general toxic effect of hybrid organotin compounds during the period of the greatest severity of the intoxication clinical picture will allow to estimate the risk of hepatotoxic and nephrotoxic complications with the administration of bis (3,5–di– tert–butyl–4–hydroxyphenylthiolate) dimethyltin (Me-3) and ((3,5–di–tert–butyl–4–hydroxyphenylthiolate) triphenyltin (M-e5) as chemotherapeutic agents.
Аim: To conduct a comparative analysis of morphological and biochemical changes with a single intragastric administration of hybrid organotin compounds Me-3 and Me-5 in the maximum tolerated dose (MTD) on the 7th day of the toxic process development.
Material and Methods. Hybrid organotin compounds Me-3 and Me-5 were administered once intragastrically to Wistar rats (females) at a MTD of 2000 mg/kg and 750 mg/kg, respectively. Biochemical and morphological studies were carried out on the 7th day of the development of intoxication symptoms according to standard methods.
Results. With the introduction of Me-3 and Me-5 in the liver, signs of fatty dystrophy of varying severity were revealed, with a predominant lesion of centrolobular hepatocytes, an increase in the size of portal tracts due to edema and fibrosis, and scant lymphocytic infiltration. With the introduction of Me-5, morphological changes were more severe, with the involvement of the vascular bed of the organ in the process. When the tested compounds were administered in the kidneys, the same type of damage to the glomerular apparatus and renal tubules was recorded, characteristic of toxic nephropathy. Unidirectional changes in the blood of experimental animals were revealed in the group of nonspecific biochemical markers of cytolysis: a moderate decrease in transaminase activity and an increase in the activity of creatine kinase (CC), lactate dehydrogenase (LDH) and creatinine levels. The process of formation of urea and protein synthesis was functionally preserved.
Conclusion. On the 7th day of the development of intoxication with a single intragastric administration of hybrid organotin compounds Me-3 and Me-5 in the maximum tolerated doses, biochemical and morphological changes in the body of animals could be attributed to a moderate degree of severity.
Keywords
About the Authors
M. A. DodokhovaRussian Federation
Margarita A. Dodokhova - Cand. Sci. (Med.), Associate Professor, Department of Pathological Physiology, Rostov State Medical University of the Ministry of Healthcare of the Russian Federation.
29, Nakhichevan lane, Rostov-on-Don, 344022
O. V. Voronova
Russian Federation
Olga V. Voronova - Head of the Pathological Department, Private Health Care Institution “Rostov-on-Don Clinical Hospital “Russian Railways-Medicine”; Assistant Professor, Department of Forensic Medicine, Rostov State Medical University of the Ministry of Healthcare of the Russian Federation.
29, Nakhichevan lane, Rostov-on-Don, 344022; 92a, Varfolomeeva str., Rostov-on-Don, 344011
I. M. Kotieva
Russian Federation
Inga М. Kotieva - Dr. Sci. (Med.), Professor, Pathological Physiology Department, Vice-Rector for Scientific Work, Rostov State Medical University of the Ministry of Healthcare of the Russian Federation.
29, Nakhichevan lane, Rostov-on-Don, 344022
A. V. Safronenko
Russian Federation
Andrey V. Safronenko - Dr. Sci. (Med.), Head, Department of Pharmacology and Clinical Pharmacology, Rostov State Medical University of the Ministry of Healthcare of the Russian Federation.
29, Nakhichevan lane, Rostov-on-Don, 344022
S. V. Shlyk
Russian Federation
Sergey V. Shlyk - Dr. Sci. (Med.), Professor, Rector, Rostov State Medical University of the Ministry of Healthcare of the Russian Federation.
29, Nakhichevan lane, Rostov-on-Don, 344022
N. V. Drobotya
Russian Federation
Natalia V. Drobotya - Dr. Sci. (Med.), Professor, Head, Department of Cardiology, Rheumatology and Functional Diagnostics, Vice-Rector for Academic Affairs, Rostov State Medical University of the Ministry of Healthcare of the Russian Federation.
29, Nakhichevan lane, Rostov-on-Don, 344022
M. A. Akimenko
Russian Federation
Marina A. Akimenko - Вiologist of the Highest Category, Pathological department, Private Health Care Institution “Rostov-on-Don Clinical Hospital “Russian Railways-Medicine”; Assistant Professor, Department of Biology, Rostov State Medical University of the Ministry of Healthcare of the Russian Federation.
29, Nakhichevan lane, Rostov-on-Don, 344022; 92a, Varfolomeeva str., Rostov-on-Don, 344011
D. B. Shpakovsky
Russian Federation
Dmitry B. Shpakovsky - Cand. Sci. (Chem.), Senior Research Scientist, Bioelementoorganic Chemistry Research Laboratory, Department of Medical Chemistry and Fine Organic Synthesis, Faculty of Chemistry, Rostov State Medical University of the Ministry of Healthcare of the Russian Federation.
1-3, Leninskie gory str., Moscow, 119991
E. R. Milaeva
Russian Federation
Elena R. Milaeva - Dr. Sci. (Chem.), Professor, Head, Department of Medical Chemistry and Fine Organic Synthesis, Faculty of Chemistry, Rostov State Medical University of the Ministry of Healthcare of the Russian Federation.
1-3, Leninskie gory str., Moscow, 119991
References
1. Azad A., Chang P., Devuni D., Bichoupan K., Kesar V., Branch A.D. et al. Real world experience of drug induced liver injury in patients undergoing chemotherapy. J. Clin. Gastroenterol. Hepatol. 2018;2(3):18. DOI: 10.21767/2575-7733.1000047.
2. Gromova E.G., Biryukova L.S., Dzhumabaeva B.T., Kurmukov I.A. Practical recommendations for the correction of nephrotoxicity of anticancer drugs. Malignant tumors. 2020;10(3s2-2):118–130. (In Russ.). DOI: 10.18027/2224-5057-2020-10-3s2-46.
3. Dodokhova M.A., Safronenko A.V., Kotieva I.M., Sukhorukova N.V., Gantsgorn E.V., Alkhusein-Kulyaginova M.S. et al. Evaluation of the pharmacotherapeutic potential of organotin compounds in vivo. Biopharmaceutical Journal. 2021;13(3):11–15. (In Russ.). DOI: 10.30906/2073-8099-2021-13-3-11-15.
4. Dodokhova M.A., Safronenko A.V., Kotieva I.M., Komarova E.F., Trepel V.G., Alkhusein-Kulyaginova M.S. et al. Study of acute oral toxicity of organotin compounds containing a fragment of 2,6-di-tert-butylphenol. Ural Medical Journal. 2021;20(3):73–77. (In Russ.). DOI: 10.52420/2071-5943-2021-20-3-73-77.
5. Dodokhova M.A., Safronenko A.V., Kotieva I.M., Alkhuseyn-Kulyaginova M.S., Shpakovsky D.B., Milaeva E.R. Evaluation of the pharmacological activity of hybrid organotin compounds in a b16 melanoma model in the classical and metronomic administration modes. Research Results in Pharmacology. 2022;8(1):85–93. DOI: 10.3897/rrpharmacology.8.76363.
6. Dodokhova M.A., Safronenko A.V., Kotieva I.M., Alkhuseyn-Kulyaginova M.S., Shpakovsky D.B., Milaeva E.R. Impact of organotin compounds on the growth of epidermoid Lewis carcinoma. Research Results in Pharmacology. 2021;7(4):81–88. DOI: 10.3897/rrpharmacology.7.71455.
7. Medical toxicology: national guidelines / ed. by E. A. Luzhnikov. Moscow: GEOTAR-Media; 2014:928. Text: electronic. (In Russ.). URL: https://www.rosmedlib.ru/book/ISBN9785970429716.html (14.12.2022).
8. Astashkin E.I., Achkasov E.E., Berzin I.A., Beskova T.B., Bolotskikh L.A., Boyarintsev V.V. et al. The guide to laboratory animals and alternative models in biomedical researches. Moscow; 2010:358. (In Russ.).
9. Slukhanchuk E.V., Bitsadze V.O., Tyan A.G., Khizroeva D.Kh., Tretyakova M.V., Solopova A.G. et al. Risk factors for thrombosis in cancer patients. Bulletin of the Russian Academy of Medical Sciences. 2021:76(5):465–475. (In Russ.). DOI: 10.15690/vramn1459.
10. Koptyaeva K.E., Muzhikyan A.A., Gushchin Ya.A., Belyaeva E.V., Makarova M.N., Makarov V.G. Method of autopsy and extraction of organs of laboratory animals (rats). Laboratory animals for scientific research. 2018;2:71–92. (In Russ.). DOI: 10.29926/2618723X-2018-02-08.
11. Popov K.A., Tsymbalyuk I.Yu., Sepiashvili R.I., Bykov I.M., Ustinova E.S., Bykov M.I. Selection of the optimal marker of acute liver injury in rats in the experiment. Bulletin of Peoples’ Friendship University of Russia. Series: Medicine. 2020;24(4):293–303. (In Russ.). DOI: 10.22363/2313-0245-2020-24-4-293-303.
12. Dodokhova M.A., Piontik E.A. Toxic effect of organotin compoumds on the activity of alkaline phosphatase and transaminases in human serum. Bulletin of Russian State Medical University. Materials of the IX Pirogov Scientific Conferenc . Moscow; 2005:164. (In Russ.).
13. Pashina E.V., Zolotavina M.L. A complex of biochemical indicators in assessing the formation of stages of endogenous intoxication in the cell. Modern problems of science and education. 2019;(6). Text: electronic. (In Russ.). URL: https://science-education.ru/ru/article/view?id=29437 (14.12.2022).
14. Skvortsov V.V., Bangarov R.Yu., Skvortsova E.M. Nephrotic syndrome in the work of a general practitioner. Doctor. 2022;(2):77–83. (In Russ.). DOI: 10.29296/25877305-2022-02-13.
15. Rogaleva E.V., Semenenko M.P., Kuzminova E.V., Abramov A.A. Prospects for the use of a new complex hepatoprotective drug based on a plant component containing flavonoids. Collection of scientific papers of the Krasnodar Scientific Center for Animal Science and Veterinary Medicine. 2021;10(1S):99–102. (In Russ.). DOI: 10.48612/f3ta-58bz-13pu.
Review
For citations:
Dodokhova M.A., Voronova O.V., Kotieva I.M., Safronenko A.V., Shlyk S.V., Drobotya N.V., Akimenko M.A., Shpakovsky D.B., Milaeva E.R. Comparative analysis of morphological and biochemical changes after a single intragastric administration of hybrid organotin compounds. Siberian Journal of Clinical and Experimental Medicine. 2023;38(1):167-174. (In Russ.) https://doi.org/10.29001/2073-8552-2023-38-1-167-174